ASX:DVL dorsaVi (DVL) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free DVL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get dorsaVi alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About dorsaVidorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that analyzes how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes. It also offers ViPerform, a wearable and wireless movement sensor technology that offers objective data to assess risk of sport injury and guides athletic training and recovery programs; telehealth solutions; and professional suites. dorsaVi Ltd was incorporated in 2008 and is based in Melbourne, Australia.Read More Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report DVL Stock News HeadlinesDecember 18, 2023 | msn.comTop 10 at 10: All eyes are on Azure, SQM, and GinaDecember 6, 2023 | msn.comASX Small Caps Lunch Wrap: Which major climate conference is turning into a circus this week?May 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.November 16, 2023 | morningstar.comDevelia SA DVLNovember 10, 2023 | finance.yahoo.comShareholders Will Likely Find dorsaVi Ltd's (ASX:DVL) CEO Compensation AcceptableOctober 24, 2023 | msn.comASX Small Cap Lunch Wrap: ASX felled by September CPI burstAugust 28, 2023 | finance.yahoo.comdorsaVi Full Year 2023 Earnings: AU$0.004 loss per share (vs AU$0.004 loss in FY 2022)June 12, 2023 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy dorsaVi StockMay 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.April 17, 2023 | finance.yahoo.comDVL, Inc. (DVLN) Stock Historical Prices & Data - Yahoo FinanceDecember 31, 2022 | nz.finance.yahoo.comdorsaVi Ltd (ASX:DVL) insiders placed bullish bets worth AU$955k in the last 12 monthsSeptember 9, 2022 | reuters.comDVL.AX - Dorsavi Ltd | Stock Price & Latest News | ReutersSeptember 7, 2022 | fool.com.auWhy tech share Dorsavi Ltd surged higher todayAugust 27, 2022 | afr.comDorsavi LtdJuly 19, 2022 | fool.com.au5 explosive growth shares I will be watching in 2017July 18, 2022 | finance.yahoo.comMultiple insiders bought dorsaVi Ltd (ASX:DVL) stock earlier this year, a positive sign for shareholdersFebruary 17, 2022 | msn.comCheck Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASXFebruary 8, 2022 | finance.yahoo.comInsider Buying: Bilal Ahmad Just Spent AU$586k On dorsaVi Ltd (ASX:DVL) SharesFebruary 8, 2022 | finance.yahoo.comInsiders at dorsaVi Ltd (ASX:DVL) recouped some losses this week after buying this year, still down AU$122kNovember 2, 2021 | finance.yahoo.comdorsaVi Ltd (DVL.AX)September 11, 2021 | msn.com10 at 10: These ASX stocks have the most ardent support this morningAugust 14, 2021 | barrons.comdorsaVi Ltd.August 5, 2021 | msn.comClosing Bell: ASX rises again, hits all time highSee More Headlines Receive DVL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for dorsaVi and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2019Today5/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorComputer and Technology Industry Scientific & Technical Instruments Sub-IndustryN/A Current SymbolASX:DVL CUSIPN/A CIKN/A Webwww.dorsavi.com Phone1800 367 728FaxN/AEmployees34Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,550,000.00 Net Margins-105.38% Pretax MarginN/A Return on Equity-103.61% Return on Assets-52.69% Debt Debt-to-Equity Ratio11.25 Current Ratio2.38 Quick Ratio0.80 Sales & Book Value Annual Sales$1.47 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.71 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares596,660,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.97 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Andrew James Ronchi B.App.Sci.GAICD, Ph.D., Co-Founder, MD, CEO & Executive DirectorMr. Daniel Mathew Ronchi Ass.Deg.LawChief Technology OfficerMr. Aaron ChanChief Financial OfficerMr. Justin Mouchacca B.Bus (Acc)C.A., CA, Company SecretaryKey CompetitorsAERWINS TechnologiesNASDAQ:AWINWCatapult Group InternationalASX:CATCeptonNASDAQ:CPTNWCodanOTCMKTS:CODAFCodanASX:CDAView All CompetitorsInsidersCaroline ElliottSold 1,000,001 sharesTotal: $11,000.01 ($0.01/share)Caroline ElliottSold 1,000,001 sharesTotal: $11,000.01 ($0.01/share) DVL Stock Analysis - Frequently Asked Questions How were dorsaVi's earnings last quarter? dorsaVi Ltd (ASX:DVL) announced its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) EPS for the quarter. dorsaVi had a negative trailing twelve-month return on equity of 103.61% and a negative net margin of 105.38%. What other stocks do shareholders of dorsaVi own? Based on aggregate information from My MarketBeat watchlists, some companies that other dorsaVi investors own include Myriad Genetics (MYGN), Akers Biosciences (AKER), Alder Biopharmaceuticals (ALDR), Argos Therapeutics (ARGSQ), Aramark (ARMK), Bellerophon Therapeutics (BLPH), BioLineRx (BLRX), Audentes Therapeutics (BOLD), Auxly Cannabis Group (CBWTF). This page (ASX:DVL) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding dorsaVi Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
